Dr. Amar Rewari Discusses the Galleri Cancer Test on Super Age

Recently, Dr. Amar Rewari, Chief of Radiation Oncology at Luminis Health, was featured in a Super Age article titled "The Galleri Cancer Test: Worth It for Early Detection or Not?" The article explores the effectiveness of multi-cancer early detection (MCED) tests, specifically the Galleri test, which claims to spot over 50 types of cancer using a single blood sample.

In the feature, Dr. Rewari shared his professional perspective on how patients should approach these new screening technologies. While acknowledging their potential, he emphasized that MCED tests are not yet a substitute for standard, doctor-recommended procedures. He noted, "It should be viewed as something that adds to, rather than replaces, the proven cancer screening tools we already have."

Dr. Rewari also discussed the ideal candidates for these tests. He cautioned that younger, lower-risk individuals might face unnecessary anxiety and financial costs from false positives. He advised that people who are "not prepared for the possibility of extra scans or biopsies if the test shows something may not benefit as much."